Christian Leisner

Christian Leisner, the CEO and co-founder of CDR Life, a biotech innovator in targeted T-cell immunotherapies, shares insights from his impressive career. He discusses the challenges of funding and intellectual property in biotech, and the exciting potential of CDR404, a promising T-cell engager designed for cancer treatment. Leisner also highlights the adaptability of their platform for autoimmune diseases, and the rapid advancements in oncology drug development. Plus, his choice of historical figures for dinner reveals his love for exploration and intellectual discourse.